AutoGen vs Google DeepMind
Side-by-side trajectory, velocity, and editorial themes.
AutoGen has gone quiet — last release was September 2025, with no public update for nearly eight months.
AutoGen's most recent release is python-v0.7.5 on 2025-09-30. The last sustained activity came in a Q3 2025 cluster: v0.7.0 through v0.7.5, with v0.7.1 introducing nested Teams as group-chat participants, RedisMemory, latest MCP version, and OpenAIAgent built-in tools. v0.7.2 made DockerCommandLineCodeExecutor the default for MagenticOne and added an approval_func to CodeExecutorAgent. After that, the cadence stops cold — eight months of public silence as of May 2026.
The technical arc through July–September 2025 was clear: deeper team composition (teams-as-tools, teams-as-participants), better memory (RedisMemory, GraphFlow state retention across resumes), and an MCP-aligned tool surface. Then nothing. For a Microsoft research project in the agent-framework space, an eight-month gap during the most competitive period in agent tooling (LangGraph, OpenAI Agents SDK, Anthropic's Claude Agent SDK, Semantic Kernel agent expansions) is not normal silence — the absence is the signal. Without a release or public roadmap statement, this reads as either pre-major-rewrite mode or quiet wind-down/absorption into another Microsoft framework.
If there is no release within the next quarter, treat AutoGen as effectively frozen for production use; the agentic framework ecosystem has moved without it. If a release does land, expect it to be a structural rewrite tied to Semantic Kernel or a Microsoft-wide agent surface rather than continuation of the 0.7.x line.
DeepMind is repositioning Gemini as the substrate for scientific research, not just consumer AI.
DeepMind's recent output is dominated by Co-Scientist case studies and the formal launch of a 'Gemini for Science' suite, with applied research wins clustered around biology — aging, ALS, liver disease, infectious disease triggers. A second strand expands consumer-facing tools (Project Genie + Street View) for Google AI Ultra subscribers and pushes on content provenance. National partnership announcements (Singapore) round out the geopolitical surface.
The center of gravity is shifting from frontier model releases to vertical applications, particularly in life sciences. Co-Scientist appears to be moving from internal project to a packaged offering institutions can collaborate on. Consumer features and content authenticity work continue in parallel but feel secondary to the science push.
Expect a formal Co-Scientist productization announcement with institutional access tiers within the next quarter, and additional 'Gemini for X' verticals (likely materials science or drug discovery) to follow the science framing.
See more alternatives to AutoGen →
See more alternatives to Google DeepMind →